1 Molecular Cancer Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia (ABS); Basser Center, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, PA (SD); Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY (MR); Department of Medicine (SB) and Department of Dermatology (DEG), Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (PR); Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos), Madrid, Spain (MdlH); Department of Human Genetics and Department of Cancer Epidemiology, Leiden University Medical Center, Leiden, the Netherlands (PD); Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL (ANAM); Department of Pathology, the University of Melbourne, Melbourne, Victoria, Australia (MS); Faculty of Medicine, University of Southampton, Southampton, UK (DE); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC).